TMO

— Fundamental Stock Analysis and Report Card

Healthcare : Medical - Diagnostics & Research

Located in Waltham, MA, US. Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.

Growth

Revenue, earnings and profitability.

Strong revenue growth and earnings can attract investors, driving the stock price up. Profitability indicates the company's efficiency and sustainability, which impacts investor confidence. Poor performance in these areas can lead to a decrease in stock price.

Revenue History

Earnings History

Margins

Gross Margin TTM
39.41%
EBITDA Margin TTM
24.69%
Net Margin TTM
15.18%
Earnings Per Share TTM
18.44
Statements

Income & Cash Flow analysis.

An income statement shows what a company earned and spent over a period — revenue at the top, costs and expenses in between, and net income at the bottom. A cash flow statement tracks the actual cash moving in and out, across operations, investing, and financing. Read together, they show whether reported earnings are backed by real cash.

Thermo Fisher Scientific Inc.
Select Period:
Q1 2026
Total ($)
Q1 2026
Margin (%)
Revenue
11.0b
+641.0m
+6.2%
Gross Income
4.5b
+231.0m
+5.4%
41%
-0.3pp
-0.7%
EBITDA
2.3b
-318.0m
-12.1%
21%
-4.4pp
-17.2%
Operating Income
1.9b
+23.0m
+1.3%
17%
-0.8pp
-4.6%
Net Income
1.7b
+144.0m
+9.6%
15%
+0.5pp
+3.2%
Earnings Per Share
4.44
+0.5
+11.3%
Operating Cash Flow
1.2b
+469.0m
+64.9%
11%
+3.9pp
+55.3%
Free Cash Flow
816.0m
+455.0m
+126.0%
7%
+3.9pp
+112.9%
Research & Development
336.0m
-6.0m
-1.8%
3%
-0.2pp
-7.5%